Oral Testosterone
Product Details
User: Male
Hormonal: Yes
Delivery Method: Oral
Duration Type: Short-acting
Duration: One day
Regimen: - daily
- daily
Active Pharmaceutical Ingredient (API): - testosterone
- testosterone
Multipurpose Preventive Technology (MPT): No
Status Details
Developer: University of Washington, GlaxoSmithKline, NICHD
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Phase I
Active Development: Unknown
Additional Information
References: ClinicalTrials.gov Identifier: NCT01167829
ClinicalTrials.gov Identifier: NCT01167829